Press Releases Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Delayed Japan Exchange Other stock markets 23:33:44 2024-04-29 EDT			5-day change	1st Jan Change
418 ^JPY	+1.95%		+2.20%	-10.30%

04-22	Lull in Geopolitical Tensions Lifts Asian Stock Markets	MT
04-17	Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sumitomo Pharma : Presentation Material (Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024)	08:13pm	PU
Sumitomo Pharma : Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	03-15	PU
Sumitomo Pharma Announces Availability of ORGOVYX in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer	03-13	AQ
Poxel Announces its Financial Calendar for 2024	01-04	AQ
Sumitomo Pharma : Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease in the United States	12-25	PU
Poxel Provides Corporate Update	12-22	AQ
Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting	12-12	AQ
Sumitomo Pharma America and Actress Holly Robinson Peete Extend Time to Go Campaign to Empower People with Overactive Bladder	11-22	AQ
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023	11-09	AQ
Malaria Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	11-08	AQ
Sumitomo Pharma : Oct. 31, 2023 Conference on Q2 FY2023 Financial Results transcript	11-06	PU
Sumitomo Pharma : Oct. 31, 2023 Conference on Q2 FY2023 Financial Results	23-10-31	PU
Sumitomo Pharma : Governance	23-10-23	PU
Sumitomo Pharma : Business	23-10-23	PU
Sumitomo Pharma : Sustainability	23-10-23	PU
Sumitomo Pharma : About Sumitomo Pharma	23-10-23	PU
Sumitomo Pharma : Top Message	23-10-23	PU
Sumitomo Pharma : Capitals	23-10-23	PU
Sumitomo Pharma : Strategy	23-10-23	PU
Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update	23-09-26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Sumitomo Pharma Co., Ltd.

Equities

4506

JP3495000006

Press Releases

Filters